Post Reply
2701-2720 of 10899
I doubt anyone here is capable of shorting it down unless you have the millions to short. I am also looking forward to collecting, maybe next week.
infancybird ( Date: 10-Mar-2012 11:50) Posted:
No wonder you talk bad about BIG because you had short position to cover. Anyway I sold most of mine at 1.68 and will really like you to short the price to S 1.30 so that I can buy back to double my profit . Thk you for your help .
chanting ( Date: 09-Mar-2012 22:31) Posted:
Shorted more of this counter, with very good gain....It is going down to $1.30 once Biomatrix is not approve by the China SFDA....See you at $1.30..
|
|
|
|
No wonder you talk bad about BIG because you had short position to cover. Anyway I sold most of mine at 1.68 and will really like you to short the price to S 1.30 so that I can buy back to double my profit . Thk you for your help .
chanting ( Date: 09-Mar-2012 22:31) Posted:
Shorted more of this counter, with very good gain....It is going down to $1.30 once Biomatrix is not approve by the China SFDA....See you at $1.30..
|
|
Shorted more of this counter, with very good gain....It is going down to $1.30 once Biomatrix is not approve by the China SFDA....See you at $1.30..
Biosensors To Develop New Manufacturing, R& D Innovation Center And Operations Headquarter In Singapore
everyday bleeding....hai...
terrible showing from this train. run so fast earlier but bang the wall in the end. Now bleeding
The door is always open when faulty and ppl still rushing in .... While the train is not moving. This counter is a failure, hope it can delist and out from the exchange no matter its short or long. Agree its not a penny stock but a orphan stock because no one cares about it....
Aiya! Not talking about the counter lah.... it's the trains...always breakdown...
chanting ( Date: 08-Mar-2012 14:33) Posted:
| SMRT is better than this counter, it still have $1.745 up $0.005 this one is hopeless.... |
|
Bite the bullet and wait.......... Good luck.
infancybird ( Date: 08-Mar-2012 14:44) Posted:
I agreed, It is ``Hopeless`` for those who are inpatient and very short term trader indeed.
BIG is no more a penny stock for quick profit . Clinical Trial take years to complete and Trial results can be either positive and negative . You need to have longer term view when investing in this stock. It is not ``hopeless`` for longterm investor .
chanting ( Date: 08-Mar-2012 14:33) Posted:
| SMRT is better than this counter, it still have $1.745 up $0.005 this one is hopeless.... |
|
|
|
I agreed, It is ``Hopeless`` for those who are inpatient and very short term trader indeed.
BIG is no more a penny stock for quick profit . Clinical Trial take years to complete and Trial results can be either positive and negative . You need to have longer term view when investing in this stock. It is not ``hopeless`` for longterm investor .
chanting ( Date: 08-Mar-2012 14:33) Posted:
| SMRT is better than this counter, it still have $1.745 up $0.005 this one is hopeless.... |
|
SMRT is better than this counter, it still have $1.745 up $0.005 this one is hopeless....
Macham SMRT... hehehe
stocksburntme ( Date: 08-Mar-2012 13:27) Posted:
yeah a totally useless train
chanting ( Date: 08-Mar-2012 11:53) Posted:
|
|
|
yeah a totally useless train
chanting ( Date: 08-Mar-2012 11:53) Posted:
Masak one.... lol
stocksburntme ( Date: 08-Mar-2012 11:35) Posted:
| choo choo train.. lai liao |
|
|
|
Masak one.... lol
stocksburntme ( Date: 08-Mar-2012 11:35) Posted:
| choo choo train.. lai liao |
|
choo choo train.. lai liao
Train is running now. Good volume today. Good luck.
BIG annouced commencing clinical trial in China around Aug 2009. Assuming commenced clinical trial in Sept/Oct 2009 and 2 year results completed end Sept/Oct 2009 and take 3 months to collate and prepare data for submission. Data submitted in Nov/Dec 2011- this means can expect results of SFDA approval to be announced (90+35 DAYS), I.E APPROVAL TO BE ANNOUNCED IN APRIL/MAY 2012.
Of course this assume that SFDA is content with 2 years data and that Biomatrix submit trial data in end Nov/Dec 2011.
Process Applicabe for Biomatrix Obtaining SFDA approval for China
- Prepare the device design dossier in Chinese. The customer or application company can complete this.
- If Class II or III, it must be submitted for in-country testing by a SFDA-approved laboratory. Testing outside of China is not allowed at this time.
- If clinical trials are needed, then it must undergo in-country clinical trials.
- When all necessary testing is complete, submit to the SFDA. The SFDA evaluation center will review within 90 working days. If the device is approved, the SFDA final approval will be complete within an additional 35 days.
ricourean ( Date: 06-Mar-2012 22:35) Posted:
not aimlessly, ... just waiting ...waiting for China's State Food and Drug Agency, SFDA to announce approval of Biomatrix use and reimbursement in China. |
|
KEY IDEAHealthcare Sector: Back in the limelight?Summary: During the recently concluded 4QCY11 results period, Raffles Medical Group reported results which were in line with our expectations, while Biosensors International Group’s (BIG) core earnings came in slightly below our estimates. Nevertheless, both healthcare companies continued to showcase healthy growth trends. During 2010, the Healthcare sector created substantial investor fervour after the privatisation of Parkway Holdings and Thomson Medical Centre at rich valuations. Looking ahead, we believe that the Healthcare sector could return to the limelight again should the high-profile IPOs of Khazanah’s Integrated Healthcare Holdings and Fortis Healthcare’s business trust materialise. This could result in a re-rating of the sector, of which RMG would be the biggest beneficiary, in our opinion. We reiterate our OVERWEIGHTrating on the Healthcare sector, underpinned by robust fundamentals. Meanwhile, BIG [BUY FV: S$1.95] remains our top pick in the sector. from OCBC research
ricourean ( Date: 06-Mar-2012 22:35) Posted:
not aimlessly, ... just waiting ...waiting for China's State Food and Drug Agency, SFDA to announce approval of Biomatrix use and reimbursement in China. |
|
not aimlessly, ... just waiting ...waiting for China's State Food and Drug Agency, SFDA to announce approval of Biomatrix use and reimbursement in China.
